Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment initiated in phase III atamestane trial

Aug. 19, 2002

Viragen and U. of Miami collaborate on immune enhancing drug for cancer

Aug. 19, 2002

Novel EGFR inhibitors in early development at Boehringer Ingelheim

Aug. 14, 2002

FDA approves Eloxatin for advanced colorectal cancer

Aug. 14, 2002

ANO-2, a novel cyclic peroxide, shows multifunctional antiangiogenic and antitumor activity

Aug. 14, 2002

VNP-40101M enters phase I trial in leukemia

Aug. 13, 2002

OC-1012 completes phase I trial

Aug. 13, 2002

Second phase I study of huN901-DM1 under way

Aug. 13, 2002

Cancer targets selected from Exelixis and Bristol-Myers Squibb collaboration

Aug. 13, 2002

First in vitro study of P80DOX-NP completed

Aug. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.